Production (Stage)
bluebird bio, Inc.
BLUE
$4.98
-$0.02-0.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.71M | 38.52M | 10.61M | 16.10M | 18.56M |
| Total Other Revenue | -- | 0.00 | -- | -- | 12.00K |
| Total Revenue | 38.71M | 38.52M | 10.61M | 16.10M | 18.57M |
| Cost of Revenue | 12.24M | 22.79M | 11.78M | 28.95M | 25.86M |
| Gross Profit | 26.48M | 15.73M | -1.17M | -12.85M | -7.29M |
| SG&A Expenses | 35.40M | 36.80M | 45.71M | 56.25M | 51.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.22M | 75.03M | 74.72M | 104.49M | 97.27M |
| Operating Income | -21.51M | -36.51M | -64.11M | -88.39M | -78.69M |
| Income Before Tax | -28.97M | -28.61M | -60.87M | -81.37M | -69.80M |
| Income Tax Expenses | 100.00K | 107.00K | -58.00K | 21.00K | -- |
| Earnings from Continuing Operations | -29.07M | -28.71M | -60.81M | -81.39M | -69.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.07M | -28.71M | -60.81M | -81.39M | -69.80M |
| EBIT | -21.51M | -36.51M | -64.11M | -88.39M | -78.69M |
| EBITDA | -5.96M | -22.60M | -48.76M | -71.87M | -63.22M |
| EPS Basic | -2.98 | -2.95 | -6.27 | -8.40 | -7.23 |
| Normalized Basic EPS | -1.41 | -1.84 | -3.74 | -5.25 | -4.52 |
| EPS Diluted | -2.98 | -2.95 | -6.27 | -8.40 | -7.23 |
| Normalized Diluted EPS | -1.41 | -1.84 | -3.74 | -5.25 | -4.52 |
| Average Basic Shares Outstanding | 9.75M | 9.72M | 9.69M | 9.69M | 9.66M |
| Average Diluted Shares Outstanding | 9.75M | 9.72M | 9.69M | 9.69M | 9.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |